NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

Stability of coagulation assays performed in plasma from citrated whole blood transported at ambient temperature.

Author(s): Zürcher M, Sulzer I, Barizzi G, Lämmle B, Alberio L

Publication: Thromb Haemost, 2008, Vol. 99, Page 416-26

PubMed ID: 18278194 PubMed Review Paper? No

Purpose of Paper

The purpose of this paper was to determine the effects of ambient temperature transport on citrated blood on coagulation assays

Conclusion of Paper

Freezing of blood specimens resulted in increased activated partial thromboplastin time (aPTT) and decreased coagulant activity of factor V. No further significant effects of freezing specimens after transport or transport during the summer versus the winter were observed. Declines of more than 10% in factor V and factor VIII activity and in protein S levels were observed after 24-28 h of transport. After 48-52 h of transport, the coagulant activity of factor VII decreased. Correspondingly, a more than 10% decline in Prothrombin time (PT), and increase in aPTT were found in specimens transported for 48-52 h. While differences in D-dimer and activated protein C (APC) were observed, they remained under the 10% deviation necessary to be labeled as clinically significant. The authors conclude that with the exception of coagulant activity of factor V and VII, transport of blood specimens for up to 24-28 h does not result in clinically significant changes.

Studies

  1. Study Purpose

    The purpose of this study was to evaluate the effect of specimen freezing on coagulation parameters in citrated blood from a single patient.

    Summary of Findings:

    Freezing of blood specimens resulted in an 8% increase in aPTT and a 22% decrease in the coagulant activity of factor V. All other parameters were not affected by specimen freezing.

    Biospecimens
    Preservative Types
    • Frozen
    • None (Fresh)
    Diagnoses:
    • Not specified
    Platform:
    AnalyteTechnology Platform
    Morphology Hematology/ auto analyzer
    Glycoprotein Hematology/ auto analyzer
    Protein Hematology/ auto analyzer
    Peptide Hematology/ auto analyzer
    Protein ELISA
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Biospecimen Preservation Type of fixation/preservation Frozen
    None (fresh)
    Biospecimen Acquisition Anticoagulant Sodium citrate
  2. Study Purpose

    The purpose of this study was to determine the effects of transport of citrated blood specimens at ambient temperatures and subsequent freezing of plasma on coagulation parameters in specimens from patients not receiving anticoagulants and those on vitamin k antagonists. The coagulant activity of factor V and aPTT were corrected for freeze thaw effects as necessary.

    Summary of Findings:

    No significant differences were found between transport during the summer versus the winter or in fresh versus frozen specimens. Lactate dehydrogenase and hemolysis both increased during transport, but all specimens remained within the normal range. PT declined significantly in specimens transported for 24-28 h (6%) or 48-52 h (16%) which the authors attribute to declines in the coagulant activity of factor V after transport for 24-28h (12.4%) and 48-52h (27%) and factor VII after transport for 48-52h (12.8%). Interestingly the decline in PT was only present in specimens with low-normal PT values and not in specimens from patients receiving vitamin k antagonists. Similar to PT, aPTT increased significantly in specimens transported for 24-28h (5.6%) or 48-52 h (10.2%) which the authors attribute to significant declines in the coagulant activity of factors VIII and V after transport for 24-28 h (12.4% and 26.9%, respectively) or 48-52 h (27% and 32.5%, respectively). D-dimer values increased by 9.4% after transport for 48-52 h which would have led to 2% false positive and 9% false negative rates for excluding venous thromboembolism. Resistance to APC declined in specimens that were not heterozygous for the factor V Leiden mutation and were transported for 48-52 h, but the decline did not result in specimens entering the pathological range. In contrast, antithrombin (AT) did not change significantly with transport, but a slight increase did occur resulting in a specimen with low AT becoming normal. No change with storage was observed on the activity of factors II, X, IX, or XI or on the levels of fibrinogen, protein C, free protein S and the thrombin-AT complex. The authors conclude that with the exception of factor V and VII activity, transport of blood specimens for up to 24-28 h does not result in clinically significant changes in the coagulation parameters analyzed.

    Biospecimens
    Preservative Types
    • Frozen
    • None (Fresh)
    Diagnoses:
    • Not specified
    Platform:
    AnalyteTechnology Platform
    Morphology Hematology/ auto analyzer
    Protein Hematology/ auto analyzer
    Peptide Hematology/ auto analyzer
    Glycoprotein Hematology/ auto analyzer
    Protein ELISA
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Biospecimen Acquisition Anticoagulant Sodium citrate
    Biospecimen Preservation Type of fixation/preservation Frozen
    None (fresh)
    Preaquisition Other drugs Vitamin K antagonists
    Preaquisition Patient genotype Factor V Leiden mutation
    Storage Specimen transport duration/condition <1 h
    4-6 h
    8-12 h
    24-28 h
    48-52 h
    Ambient winter (-12 degrees C to 25 degrees C)
    Ambient summer (11-29 degrees C)
    Storage Within hospital transportation method Pneumatic tube system
    Hand-delivered
    Biospecimen Aliquots and Components Centrifugation Centrifugation delays investigated

You Recently Viewed  

News and Announcements

  • Most Downloaded SOPs in 2024

  • New Articles on the GTEx Project are Now FREELY Available!

  • Just Published!

  • More...